Neufeld, Nicholas H. http://orcid.org/0000-0002-8046-0212
Oliver, Lindsay D. http://orcid.org/0000-0003-2163-7257
Mulsant, Benoit H. http://orcid.org/0000-0002-0303-6450
Alexopoulos, George S. http://orcid.org/0000-0001-5677-7001
Hoptman, Matthew J. http://orcid.org/0000-0003-4485-6102
Tani, Hideaki
Marino, Patricia
Meyers, Barnett S. http://orcid.org/0000-0002-8371-8004
Rothschild, Anthony J.
Whyte, Ellen M.
Bingham, Kathleen S.
Flint, Alastair J.
Voineskos, Aristotle N. http://orcid.org/0000-0003-0156-0395
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH099167, U01MH062518, U01MH062624, U01MH062565, U01MH062446)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 9 January 2023
Revised: 2 May 2023
Accepted: 11 May 2023
First Online: 31 May 2023
Competing interests
: NHN receives grant support from the Brain and Behavior Research Foundation (BBRF), Canadian Institutes of Health Research (CIHR), Physicians’ Services Incorporated Foundation, Labatt Family Network for Research on the Biology of Depression, and the University of Toronto; this work was supported in part by an Academic Scholars Award from the Department of Psychiatry, University of Toronto. Dr Oliver receives grant support from the BBRF. BHM holds and receives support from the Labatt Family Chair in Biology of Depression in Late-Life Adults at the University of Toronto. He currently receives or has received research support during the past three years from Brain Canada, CIHR, CAMH Foundation, Patient-Centered Outcomes Research Institute (PCORI), US National Institutes of Health (NIH), Capital Solution Design LLC (software used in a study funded by CAMH Foundation), and HAPPYneuron (software used in a study funded by Brain Canada). Within the past three years, he has also been an unpaid consultant to Myriad Neuroscience. He directly owns stocks of General Electric (less than $5000). GSA has received National Institute of Mental Health (NIMH) grants and has served in the speakers bureau of Takeda, Lundbeck, Otsuka, Alergan, Astra/Zeneca, and Sunovion. MJH has received an American Foundation for Suicide Prevention grant and NIMH subcontract funding during the conduct of this study. HT was supported by a Postdoctoral Fellowship from CIHR. He has received manuscript or speaker fees from Dainippon Sumitomo Pharma, Janssen Pharmaceutical, Otsuka Pharmaceutical, Takeda, Wiley Japan, and Yoshitomi Yakuhin. PM received research support from the NIMH at the time this work was done. BSM received research support from the NIMH at the time this work was done. AJR has received grant or research support from Janssen, Otsuka, and the Irving S. and Betty Brudnick Endowed Chair in Psychiatry; is a consultant to Daiichi Sankyo, Inc., Sage Therapeutics, Xenon Pharmaceuticals, and Neumora Therapeutics; and has received royalties for the Rothschild Scale for Antidepressant Tachyphylaxis (RSAT)®, Clinical Manual for the Diagnosis and Treatment of Psychotic Depression, American Psychiatric Press, 2009; The Evidence-Based Guide to Antipsychotic Medications, American Psychiatric Press, 2010; The Evidence-Based Guide to Antidepressant Medications, American Psychiatric Press, 2012, and from UpToDate®. EMW receives grant support from the NIMH and Health Resources and Services Administration. KSB receives grant support from the University of Toronto. AJF has received grant support from the US NIH, PCORI, CIHR, Brain Canada, Ontario Brain Institute, Alzheimer’s Association, AGE-WELL, Canadian Foundation for Healthcare Improvement, and University of Toronto. ANV receives funding from the NIMH, CIHR, Canada Foundation for Innovation, CAMH Foundation, and the University of Toronto.